Please use this identifier to cite or link to this item:
|Title:||Pulse pressure variation-guided fluid therapy after cardiac surgery: a pilot before-and-after trial.||Austin Authors:||Suzuki, Satoshi;Woinarski, Nicholas C Z;Lipcsey, Miklos;Candal, Cristina Lluch;Schneider, Antoine G;Glassford, Neil J;Eastwood, Glenn M ;Bellomo, Rinaldo||Affiliation:||Australian and New Zealand Intensive Care Research Centre, School of Public Health and Preventative Medicine, Monash University, Melbourne, Victoria, Australia
Monash University, Faculty of Medicine, Nursing and Health Sciences, Melbourne, Victoria, Australia
Department of Intensive Care, Austin Health, Heidelberg, Victoria, Australia
Department of Surgical Sciences, Anaesthesiology and Intensive Care, Uppsala University, Uppsala, Sweden.
Department of Intensive Care, Hospital Universitari Mutua Terrassa, Barcelona, Spain.
Intensive Care Medicine, Universite de LaUSAnne, LaUSAnne, Switzerland.
|Issue Date:||7-Aug-2014||Publication information:||Journal of Critical Care 2014; 29(6): 992-6||Abstract:||The aim of this study is to study the feasibility, safety, and physiological effects of pulse pressure variation (PPV)-guided fluid therapy in patients after cardiac surgery.We conducted a pilot prospective before-and-after study during mandatory ventilation after cardiac surgery in a tertiary intensive care unit. We introduced a protocol to deliver a fluid bolus for a PPV≥13% for at least >10 minutes during the intervention period.We studied 45 control patients and 53 intervention patients. During the intervention period, clinicians administered a fluid bolus on 79% of the defined PPV trigger episodes. Median total fluid intake was similar between 2 groups during mandatory ventilation (1297 mL [interquartile range 549-1968] vs 1481 mL [807-2563]; P=.17) and the first 24 hours (3046 mL [interquartile range 2317-3982] vs 3017 mL [2192-4028]; P=.73). After adjusting for several baseline factors, PPV-guided fluid management significantly increased fluid intake during mandatory ventilation (P=.004) but not during the first 24 hours (P=.47). Pulse pressure variation-guided fluid therapy, however, did not significantly affect hemodynamic, renal, and metabolic variables. No serious adverse events were noted.Pulse pressure variation-guided fluid management was feasible and safe during mandatory ventilation after cardiac surgery. However, its advantages may be clinically small.||Gov't Doc #:||25220528||URI:||https://ahro.austin.org.au/austinjspui/handle/1/12390||DOI:||10.1016/j.jcrc.2014.07.032||Journal:||Journal of Critical Care||URL:||https://pubmed.ncbi.nlm.nih.gov/25220528||Type:||Journal Article||Subjects:||Cardiac output
Pulse pressure variation
Analysis of Variance
Cardiac Surgical Procedures
Controlled Before-After Studies
Fluid Therapy.adverse effects.methods
|Appears in Collections:||Journal articles|
Show full item record
checked on Dec 7, 2023
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.